Sofinnova Partners raises EUR300m healthcare fund
Sofinnova Partners, a European venture capital firm specialised in Life Sciences, has closed Sofinnova Capital VIII at EUR300 million, above the initial fund target of EUR250 million. Following the raise of its previous fund at EUR240m in 2012, this new fund brings the total amount under management at Sofinnova Partners
